Migraine Drugs Market Research Report by Therapeutic Class (Anti-Nausea Drug, Blood Pressure Lowering Medication, Ergots, Opioid Medication, and Pain Reliever), by Treatment Type (Abortive and Preventive), by Route of Administration, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Migraine Drugs Market is expected to grow from USD 3,075.35 Million in 2020 to USD 6,133.56 Million by the end of 2025.
2. The Global Migraine Drugs Market is expected to grow from EUR 2,696.53 Million in 2020 to EUR 5,378.02 Million by the end of 2025.
3. The Global Migraine Drugs Market is expected to grow from GBP 2,397.22 Million in 2020 to GBP 4,781.07 Million by the end of 2025.
4. The Global Migraine Drugs Market is expected to grow from JPY 328,218.41 Million in 2020 to JPY 654,606.78 Million by the end of 2025.
5. The Global Migraine Drugs Market is expected to grow from AUD 4,465.82 Million in 2020 to AUD 8,906.75 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Migraine Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Therapeutic Class, the Migraine Drugs Market studied across Anti-Nausea Drug, Blood Pressure Lowering Medication, Ergots, Opioid Medication, Pain Reliever, and Triptans. The Anti-Nausea Drug further studied across Chlorpromazine, Metoclopramide, and Prochlorperazine. The Blood Pressure Lowering Medication further studied across Beta-Blocker and Calcium Channel Blocker. The Ergots further studied across Dihydroergotamines, Ergotamine, and Lasmiditan. The Opioid Medication further studied across OxyContin, Percocet, and Vicodin. The Pain Reliever further studied across Aspirin and Ibuprofen. The Triptans further studied across Rizatriptan and Sumatriptan.
Based on Treatment Type, the Migraine Drugs Market studied across Abortive and Preventive.
Based on Route of Administration, the Migraine Drugs Market studied across Injectable, Nasal Spray, and Oral.
Based on Distribution, the Migraine Drugs Market studied across Hospitals Based Pharmacy, Online Pharmacy, and Retail Pharmacy.
Based on Geography, the Migraine Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Migraine Drugs Market including Aegis Therapeutics, Alder Biopharmaceuticals, Allergan, Eli Lilly, GlaxoSmithKline, Impax Laboratories, Johnson & Johnson, Luitpold Pharmaceuticals, Pfizer, TG Therapeutics, and Winston Pharmaceuticals.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Migraine Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Migraine Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Migraine Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Migraine Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Migraine Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Migraine Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Migraine Drugs Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Migraine Drugs Market is expected to grow from USD 3,075.35 Million in 2020 to USD 6,133.56 Million by the end of 2025.
2. The Global Migraine Drugs Market is expected to grow from EUR 2,696.53 Million in 2020 to EUR 5,378.02 Million by the end of 2025.
3. The Global Migraine Drugs Market is expected to grow from GBP 2,397.22 Million in 2020 to GBP 4,781.07 Million by the end of 2025.
4. The Global Migraine Drugs Market is expected to grow from JPY 328,218.41 Million in 2020 to JPY 654,606.78 Million by the end of 2025.
5. The Global Migraine Drugs Market is expected to grow from AUD 4,465.82 Million in 2020 to AUD 8,906.75 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Migraine Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Therapeutic Class, the Migraine Drugs Market studied across Anti-Nausea Drug, Blood Pressure Lowering Medication, Ergots, Opioid Medication, Pain Reliever, and Triptans. The Anti-Nausea Drug further studied across Chlorpromazine, Metoclopramide, and Prochlorperazine. The Blood Pressure Lowering Medication further studied across Beta-Blocker and Calcium Channel Blocker. The Ergots further studied across Dihydroergotamines, Ergotamine, and Lasmiditan. The Opioid Medication further studied across OxyContin, Percocet, and Vicodin. The Pain Reliever further studied across Aspirin and Ibuprofen. The Triptans further studied across Rizatriptan and Sumatriptan.
Based on Treatment Type, the Migraine Drugs Market studied across Abortive and Preventive.
Based on Route of Administration, the Migraine Drugs Market studied across Injectable, Nasal Spray, and Oral.
Based on Distribution, the Migraine Drugs Market studied across Hospitals Based Pharmacy, Online Pharmacy, and Retail Pharmacy.
Based on Geography, the Migraine Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Migraine Drugs Market including Aegis Therapeutics, Alder Biopharmaceuticals, Allergan, Eli Lilly, GlaxoSmithKline, Impax Laboratories, Johnson & Johnson, Luitpold Pharmaceuticals, Pfizer, TG Therapeutics, and Winston Pharmaceuticals.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Migraine Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Migraine Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Migraine Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Migraine Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Migraine Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Migraine Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Migraine Drugs Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Type Outlook
3.4. Route of Administration Outlook
3.5. Therapeutic Class Outlook
3.6. Distribution Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MIGRAINE DRUGS MARKET, BY THERAPEUTIC CLASS
6.1. Introduction
6.2. Anti-Nausea Drug
6.2.1. Chlorpromazine
6.2.2. Metoclopramide
6.2.3. Prochlorperazine
6.3. Blood Pressure Lowering Medication
6.3.1. Beta-Blocker
6.3.2. Calcium Channel Blocker
6.4. Ergots
6.4.1. Dihydroergotamines
6.4.2. Ergotamine
6.4.3. Lasmiditan
6.5. Opioid Medication
6.5.1. OxyContin
6.5.2. Percocet
6.5.3. Vicodin
6.6. Pain Reliever
6.6.1. Aspirin
6.6.2. Ibuprofen
6.7. Triptans
6.7.1. Rizatriptan
6.7.2. Sumatriptan
7. GLOBAL MIGRAINE DRUGS MARKET, BY TREATMENT TYPE
7.1. Introduction
7.2. Abortive
7.3. Preventive
8. GLOBAL MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Introduction
8.2. Injectable
8.3. Nasal Spray
8.4. Oral
9. GLOBAL MIGRAINE DRUGS MARKET, BY DISTRIBUTION
9.1. Introduction
9.2. Hospitals Based Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. AMERICAS MIGRAINE DRUGS MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC MIGRAINE DRUGS MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Aegis Therapeutics
14.2. Alder Biopharmaceuticals
14.3. Allergan
14.4. Eli Lilly
14.5. GlaxoSmithKline
14.6. Impax Laboratories
14.7. Johnson & Johnson
14.8. Luitpold Pharmaceuticals
14.9. Pfizer
14.10. TG Therapeutics
14.11. Winston Pharmaceuticals
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Type Outlook
3.4. Route of Administration Outlook
3.5. Therapeutic Class Outlook
3.6. Distribution Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MIGRAINE DRUGS MARKET, BY THERAPEUTIC CLASS
6.1. Introduction
6.2. Anti-Nausea Drug
6.2.1. Chlorpromazine
6.2.2. Metoclopramide
6.2.3. Prochlorperazine
6.3. Blood Pressure Lowering Medication
6.3.1. Beta-Blocker
6.3.2. Calcium Channel Blocker
6.4. Ergots
6.4.1. Dihydroergotamines
6.4.2. Ergotamine
6.4.3. Lasmiditan
6.5. Opioid Medication
6.5.1. OxyContin
6.5.2. Percocet
6.5.3. Vicodin
6.6. Pain Reliever
6.6.1. Aspirin
6.6.2. Ibuprofen
6.7. Triptans
6.7.1. Rizatriptan
6.7.2. Sumatriptan
7. GLOBAL MIGRAINE DRUGS MARKET, BY TREATMENT TYPE
7.1. Introduction
7.2. Abortive
7.3. Preventive
8. GLOBAL MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Introduction
8.2. Injectable
8.3. Nasal Spray
8.4. Oral
9. GLOBAL MIGRAINE DRUGS MARKET, BY DISTRIBUTION
9.1. Introduction
9.2. Hospitals Based Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. AMERICAS MIGRAINE DRUGS MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC MIGRAINE DRUGS MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Aegis Therapeutics
14.2. Alder Biopharmaceuticals
14.3. Allergan
14.4. Eli Lilly
14.5. GlaxoSmithKline
14.6. Impax Laboratories
14.7. Johnson & Johnson
14.8. Luitpold Pharmaceuticals
14.9. Pfizer
14.10. TG Therapeutics
14.11. Winston Pharmaceuticals
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CANADA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MEXICO MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. CHINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. CHINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. JAPAN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. JAPAN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. JAPAN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. JAPAN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. THAILAND MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. FRANCE MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. FRANCE MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. FRANCE MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. GERMANY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. GERMANY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. GERMANY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. GERMANY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. ITALY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. ITALY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. ITALY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. ITALY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. QATAR MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. QATAR MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. QATAR MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. QATAR MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. SPAIN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. SPAIN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. SPAIN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. SPAIN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. GLOBAL MIGRAINE DRUGS MARKET: SCORES
TABLE 153. GLOBAL MIGRAINE DRUGS MARKET: BUSINESS STRATEGY
TABLE 154. GLOBAL MIGRAINE DRUGS MARKET: PRODUCT SATISFACTION
TABLE 155. GLOBAL MIGRAINE DRUGS MARKET: RANKING
TABLE 156. GLOBAL MIGRAINE DRUGS MARKET: MERGER & ACQUISITION
TABLE 157. GLOBAL MIGRAINE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 158. GLOBAL MIGRAINE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 159. GLOBAL MIGRAINE DRUGS MARKET: INVESTMENT & FUNDING
TABLE 160. GLOBAL MIGRAINE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 161. GLOBAL MIGRAINE DRUGS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CANADA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MEXICO MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. CHINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. CHINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. JAPAN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. JAPAN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. JAPAN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. JAPAN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. THAILAND MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. FRANCE MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. FRANCE MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. FRANCE MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. GERMANY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. GERMANY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. GERMANY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. GERMANY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. ITALY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. ITALY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. ITALY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. ITALY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. QATAR MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. QATAR MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. QATAR MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. QATAR MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. SPAIN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. SPAIN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. SPAIN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. SPAIN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. GLOBAL MIGRAINE DRUGS MARKET: SCORES
TABLE 153. GLOBAL MIGRAINE DRUGS MARKET: BUSINESS STRATEGY
TABLE 154. GLOBAL MIGRAINE DRUGS MARKET: PRODUCT SATISFACTION
TABLE 155. GLOBAL MIGRAINE DRUGS MARKET: RANKING
TABLE 156. GLOBAL MIGRAINE DRUGS MARKET: MERGER & ACQUISITION
TABLE 157. GLOBAL MIGRAINE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 158. GLOBAL MIGRAINE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 159. GLOBAL MIGRAINE DRUGS MARKET: INVESTMENT & FUNDING
TABLE 160. GLOBAL MIGRAINE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 161. GLOBAL MIGRAINE DRUGS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL MIGRAINE DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MIGRAINE DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 8. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL MIGRAINE DRUGS MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL MIGRAINE DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 VS 2025 (%)
FIGURE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025
FIGURE 18. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (%)
FIGURE 40. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2025
FIGURE 42. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 45. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 47. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 51. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 53. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 54. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 56. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 57. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 59. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. CANADA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MEXICO MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 65. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 67. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. CHINA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. INDIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. JAPAN MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. THAILAND MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 79. FRANCE MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GERMANY MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. ITALY MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. QATAR MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. SPAIN MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 89. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 90. GLOBAL MIGRAINE DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 91. GLOBAL MIGRAINE DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 92. GLOBAL MIGRAINE DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MIGRAINE DRUGS MARKET, BY TYPE
FIGURE 1. GLOBAL MIGRAINE DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MIGRAINE DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 8. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL MIGRAINE DRUGS MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL MIGRAINE DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 VS 2025 (%)
FIGURE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025
FIGURE 18. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (%)
FIGURE 40. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2025
FIGURE 42. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 45. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 47. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 51. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 53. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 54. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 56. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 57. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 59. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. CANADA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MEXICO MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 65. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 67. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. CHINA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. INDIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. JAPAN MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. THAILAND MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 79. FRANCE MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GERMANY MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. ITALY MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. QATAR MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. SPAIN MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 89. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 90. GLOBAL MIGRAINE DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 91. GLOBAL MIGRAINE DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 92. GLOBAL MIGRAINE DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MIGRAINE DRUGS MARKET, BY TYPE
